Literature DB >> 12059018

Tissue responses to nacreous implants in rat femur: an in situ hybridization and histochemical study.

Haihong Liao1, Harry Mutvei, Lars Hammarström, Tilmann Wurtz, Jianguo Li.   

Abstract

The interface of bone and aragonite nacre (Margaritifera, fresh water pearl mussel) was studied by in situ hybridization and a tartrate-resistant acid phosphatase (TRAP) histochemical assay. Columnar implants were inserted into rat femora for 4, 7, 14, 28 and 56 days. In medullary region, a burst of transient bone formation was observed, which propagated from the periphery towards the nacre implant. A fused interface of bone and nacre was observed at 14 days. Later, the new medullary bone was resorbed and bone marrow was re-established while a thin layer of bone tissue remained covering the implant surface. Expressions of collagen alpha1(I), osteocalcin, osteopontin mRNAs and TRAP in the surrounding tissue were monitored. Correlated with the histology events, a strong transient induction of collagen alpha1(I) and osteocalcin mRNAs as well as TRAP expression, exhibiting a peak signal intensity on day 7 and subsequent down-regulation after day 14 was observed. Osteopontin mRNA, in contrast, was expressed continuously. The degrading nacre surface appeared in direct contact with macrophages and multinucleated giant cells at both days 14 and 28. These cells expressed osteopontin mRNA intensively and some TRAP enzyme activity occasionally.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12059018     DOI: 10.1016/s0142-9612(01)00421-5

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

Review 1.  From the raw bar to the bench: Bivalves as models for human health.

Authors:  José A Fernández Robledo; Raghavendra Yadavalli; Bassem Allam; Emmanuelle Pales Espinosa; Marco Gerdol; Samuele Greco; Rebecca J Stevick; Marta Gómez-Chiarri; Ying Zhang; Cynthia A Heil; Adrienne N Tracy; David Bishop-Bailey; Michael J Metzger
Journal:  Dev Comp Immunol       Date:  2018-11-29       Impact factor: 3.636

2.  Shell extracts of the edible mussel and oyster induce an enhancement of the catabolic pathway of human skin fibroblasts, in vitro.

Authors:  Thomas Latire; Florence Legendre; Mouloud Bouyoucef; Frédéric Marin; Franck Carreiras; Muriel Rigot-Jolivet; Jean-Marc Lebel; Philippe Galéra; Antoine Serpentini
Journal:  Cytotechnology       Date:  2017-05-04       Impact factor: 2.058

3.  Calcineurin plays an important role in the shell formation of pearl oyster (Pinctada fucata).

Authors:  Changzhong Li; Yilin Hu; Jian Liang; Yawei Kong; Jing Huang; Qiaoli Feng; Shuo Li; Guiyou Zhang; Liping Xie; Rongqing Zhang
Journal:  Mar Biotechnol (NY)       Date:  2009-07-11       Impact factor: 3.619

4.  Induction of Osseointegration by Nacre in Pigs.

Authors:  Leena Leelatian; Panjit Chunhabundit; Phingphol Charoonrut; Pattapon Asvanund
Journal:  Molecules       Date:  2022-04-20       Impact factor: 4.927

5.  Osteogenic potency of nacre on human mesenchymal stem cells.

Authors:  David W Green; Hyuk-Jae Kwon; Han-Sung Jung
Journal:  Mol Cells       Date:  2015-02-05       Impact factor: 5.034

6.  Bone substitute made from a Brazilian oyster shell functions as a fast stimulator for bone-forming cells in an animal model.

Authors:  Ricardo Coringa; Eduardo Martins de Sousa; Juliana Nunes Botelho; Rafael Soares Diniz; Joicy Cortez de Sá; Maria Carmen Fontoura Nogueira da Cruz; Marco Aurelio Beninni Paschoal; Letícia Machado Gonçalves
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

Review 7.  Bioactive Compounds from Marine Organisms: Potential for Bone Growth and Healing.

Authors:  Matthew A Carson; Susan A Clarke
Journal:  Mar Drugs       Date:  2018-09-18       Impact factor: 5.118

8.  Water soluble bioactives of nacre mediate antioxidant activity and osteoblast differentiation.

Authors:  Ratna Chaturvedi; Prajjal Kanti Singha; Satyahari Dey
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.